The Cooper Companies, Inc. (COO) is well-poised for growth, backed by strong prospects in its CooperVision (CVI) and CooperSurgical (CSI) business segments. Acquisitions boost the company’s portfolio and buoy optimism. However, unfavorable currency movements and rising costs continue to hurt revenues and margins, respectively.Shares of this currently Zacks Rank #3 (Hold) company have risen 11.3% in the past year compared with the industry's 10.8% growth. The S&P 500 Index has gained 22.1% in the same time f ...

SAN RAMON, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO) today announced it will report first quarter 2024 financial results on Thursday, February 29, 2024, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 5337119. A simultaneous audio webcast and subsequent replay can be accessed at http://investor.coopercos.c ...

Financial Data and Key Metrics Changes - The company reported record revenues of almost $3.6 billion for the fiscal year 2023, representing a 9% increase year-over-year, or 10% on an organic basis [14][47] - For Q4 2023, consolidated revenues were $927 million, up 9% organically year-over-year [15][44] - Non-GAAP earnings per share (EPS) for Q4 was $3.47, up 26% year-over-year [22][46] - Consolidated gross margin improved to 66.7%, up from 65% last year, driven by better operational performance [44] Business Line Data and Key Metrics Changes - CooperVision revenues were $623 million, up 11% organically, while CooperSurgical revenues were $304 million, up 7% organically [15][34] - The daily silicone hydrogel portfolio, particularly MyDay, showed strong growth, with Daily Silicone Hydrogel lenses growing 19% [23][26] - Myopia management revenues reached $35 million, up 41%, with MiSight growing 46% [29] Market Data and Key Metrics Changes - CooperVision's growth was led by the Americas, which grew 12%, EMEA grew 9%, and Asia Pacific grew 10% [22] - The contact lens market grew approximately 7% in calendar Q3, with CooperVision taking market share and growing 10% [31] - The company expects the contact lens market to remain healthy, growing 5% to 7% in the coming year [31] Company Strategy and Development Direction - The company aims to gain market share, drive profitability, and launch innovative products while maintaining its culture [21] - There is a focus on expanding the MyDay product line and addressing capacity constraints to meet demand [40][41] - The company is also investing in geographic expansion and R&D within CooperSurgical, particularly in the fertility market [35] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving strong growth despite capacity challenges, particularly for MyDay products [40][56] - The company anticipates a solid Q1 2024, with guidance for CooperVision's organic revenue growth set at 7% to 9% for the year [40][50] - Management highlighted the ongoing demand for contact lenses and the expected long-term growth in the industry due to increasing myopia rates [32][36] Other Important Information - The company announced a four-for-one stock split effective February 16, 2024, to make ownership more accessible [52] - The acquisition of select Cook Medical assets for $300 million is expected to be accretive to non-GAAP earnings per share by approximately $0.20 in fiscal 2024 [49] Q&A Session Summary Question: What is the outlook for CooperVision's revenue growth and pricing strategy? - Management indicated that they expect to achieve around 7% growth in Q1, with capacity constraints impacting potential growth [56][57] - They confirmed that pricing will be at the higher end of market expectations, which is around 2% to 3% [57] Question: How will operating margin expansion be achieved? - Management noted that operating income grew 11% on a constant currency basis and emphasized their focus on improving operating margins [64] Question: Are there any concerns about losing customers due to capacity challenges? - Management reassured that they are not losing customers and continue to gain new wearers, although capacity constraints may limit growth [89] Question: What is the company's strategy regarding foreign exchange impacts? - Management stated that if the dollar weakens, they plan to let the benefits flow through to the bottom line [91] Question: What is the status of the MiSight product and its insurance coverage? - Management indicated that they are in the early stages of insurance coverage for MiSight, with reimbursement rates varying significantly [113][115]

CooperCompanies Fiscal 2024 financial guidance FY24 Guidance* Sales Note: Sales $ in millions; Organic growth excludes the effect of foreign currency fluctuations and the impact of any acquisitions, divestitures, or discontinuations that occurred in the comparable period. Non-GAAP and organic – a reconciliation of these measures are available under the "Reconciliation of Selected GAAP Results to Non-GAAP Results" section in our earning releases and under the "Management's Discussion and Analysis of Financia ...

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED OCTOBER 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO (925) 460-3600 (Registrant's telephone number, including area code) ________________________ Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, $.10 par valu ...

The Cooper Companies, Inc. (NASDAQ:COO) Q3 2023 Earnings Call Transcript August 30, 2023 5:00 PM ET Company Participants Kim Duncan - VP of IR & Risk Management Albert White - President and CEO Brian Andrews - Executive VP, CFO & Treasurer Conference Call Participants Jonathan Block - Stifel Lawrence Biegelsen - Wells Fargo Securities Jeffrey Johnson - Robert W. Baird Matthew Mishan - KeyBanc Capital Markets Jason Bednar - Piper Sandler Joanne Wuensch - Citigroup Bradley Bowers - Mizuho Securities Patrick W ...

FORM 10-Q _____________________________________________________________ ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended July 31, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________________________________ ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 1-8597 The Cooper Compa ...

The Cooper Companies, Inc. (NASDAQ:COO) Q2 2023 Earnings Conference Call June 1, 2023 5:00 PM ET Company Participants Kim Duncan - - VP of IR & Risk Management Albert White - President and CEO Brian Andrews - Executive VP, CFO & Treasurer Conference Call Participants Jeffrey Johnson - Robert W. Baird Lawrence Biegelsen - Wells Fargo Securities Joanne Wuensch - Citigroup Anthony Petrone - Mizuho Securities Robbie Marcus - JPMorgan Brett Fishbin - KeyBanc Capital Markets Jason Bednar - Piper Sandler Jona ...

Title of each class Trading Symbol Name of each exchange on which registered Common Stock, $.10 par value COO The New York Stock Exchange THE COOPER COMPANIES, INC. AND SUBSIDIARIES ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 FORM 10-Q _____________________________________________________________ For the transition period from to Commission File Number 1-8597 _____________________________________________________________ The Cooper Companies, Inc. (Exact name of ...

The Cooper Companies, Inc. (NASDAQ:COO) Q1 2023 Earnings Conference Call March 2, 2023 5:00 PM ET Company Participants Kim Duncan - - VP of IR & Risk Management Albert White - President and CEO Brian Andrews - Executive VP, CFO & Treasurer Conference Call Participants Jonathan Block - Stifel, Nicolaus & Company, Incorporated Lawrence Biegelsen - Wells Fargo Securities, LLC Jeffrey Johnson - Robert W. Baird & Co. Incorporated Bradley Thomas Bowers - Mizuho Securities USA LLC Jason Bednar - Piper Sandler & Co ...